MedQuest Ltd. v. Rosa

Background

MedQuest Ltd. alleged that its former employees, Christine Rosa and Carolyn Fink, misappropriated its expert database and lawyer list to establish Trimeritus Group LLC, a competing business. The amended complaint asserted claims under the federal Defend Trade Secrets Act, breach of fiduciary duty, and unfair competition.

MedQuest alleged that its expert database contained information about approximately 2,500 experts and that its lawyer list contained more than 45,000 existing and prospective medical-malpractice and personal-injury lawyers. It claimed that it protected the information through special password access, limited administrative access, difficulty printing or downloading the lists, a policy manual concerning confidential information, and statements at staff meetings. The opinion noted that the amended complaint did not explain how these protections worked or what the confidentiality policy required.

Rosa and Fink had worked for MedQuest for more than twenty years. They formed Trimeritus Group about a year before resigning from MedQuest in January 2021. MedQuest alleged that its business declined after Trimeritus was formed and that the defendants used MedQuest’s relationships and lists in their competing business.

Rule 12(b)(6) standard

The defendants moved to dismiss under Rule 12(b)(6), which allows dismissal when a complaint does not allege enough facts to state a legally plausible claim. The court accepted well-pleaded factual allegations as true for purposes of the motion but did not accept unsupported legal conclusions or speculation as facts.

Trade-secret analysis

The court held that the amended complaint did not adequately plead that the expert database and lawyer list were trade secrets. Trade-secret protection requires information to have economic value because it is not generally known or readily obtainable through proper means. The court found that the database, as described, contained public information about experts, including their names, fees, specialties, education, practice locations, hospital affiliations, curricula vitae, and testimony history. The court also found that the identities and contact information of the lawyers were generally available through directories, the internet, trade shows, and direct calls.

The court further held that MedQuest had not adequately alleged reasonable measures to protect the information’s confidentiality. MedQuest did not allege that Rosa or Fink had signed a nondisclosure, noncompete, or nonsolicitation agreement, or that they acknowledged and agreed to be bound by the policy manual. The allegations about passwords, administrative access, and restrictions on printing, downloading, or emailing were too vague to show how the measures protected the information.

The court also held that MedQuest had not adequately alleged misappropriation. The amended complaint did not specifically allege that Rosa and Fink transmitted, downloaded, printed, or otherwise took the lists without authorization. Instead, it relied on allegations made “upon information and belief” and asked the court to infer improper use from overlapping contacts and MedQuest’s decline in business. The court found those allegations speculative. It noted that common contacts were expected because the lists were extensive, Rosa and Fink had worked in the field for more than twenty years, and a decline in business could have resulted from pandemic-related court closures or ordinary competition.

State-law claims

After granting dismissal of the federal trade-secret claim, the court declined to exercise supplemental jurisdiction—the court’s authority to hear related state-law claims—over the claims for breach of fiduciary duty and unfair competition. The opinion stated that the usual balance of judicial economy, convenience, fairness, and comity favored declining jurisdiction after the federal claims were eliminated.

Leave to amend and disposition

MedQuest requested permission to amend in its opposition to the motion. The court denied that request without prejudice because it had previously explained the complaint’s defects and had already given MedQuest an opportunity to file a second amended complaint. The court stated that any later request must explain in detail how the proposed pleading addresses each defect, attach the proposed complaint and a redline, and explain why any new facts were not previously alleged.

Judge Gardephe’s order granted the defendants’ motion to dismiss and denied MedQuest’s motion for leave to amend without prejudice. The clerk was directed to terminate both motions, and the order set deadlines for any later motion to amend and the opposition to it.